Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NOAC9 - A Phase II Randomised Nordic Anal Cancer Group Study on Circulating Tumor DNA Guided Follow-Up

NCT05572801 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT05572801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05572801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NOAC9 - A Phase II Randomised Nordic Anal Cancer Group Study on Circulating Tumor DNA Guided Follow-Up
Lead sponsor
Aarhus University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 2, 2023
Completion date
June 1, 2031
Enrollment
400 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer